BRAF and Miyoshi myopathy: Regarding this same topic, another study used a method based on an allele-specific qPCR (Taqman) with higher sensitivity because of the presence of a peptide nucleic acid designed to inhibit amplification of the wt allele for detection and quantification of BRAF V600E, in ctDNA isolated from plasma and serum from 22 MM patients treated with BRAFi [111].